Phosphate metabolites hormone receptors benign malignant breast tumors Nuclear Magnetic Resonance study Phosphorous nuclear magnetic resonance NMR spectra perchloric acid extracts benign malignant breast tumors spectra histopathologic diagnosis steroid receptor status tumor relative content lipid-derived metabolite glycerolphosphoethanolamine GPE high-energy nucleoside phosphates nucleoside-diphosphate NDP nucleoside-triphosphate NTP sugar esters uridine diphosphate UDPS carcinomas Malignant tumors ratio phosphoethanolamine PE/PC benign conditions Lower content lipid-derived metabolite glycerolphosphocholine GPC high content high-energy compound phosphocreatine PCr malignant tumors high content estrogen receptors ER High PCr content carcinomas high progesterone receptors PgR content benign tumors NDP NTP tumors high PgR content authors magnetic resonance spectroscopy MRS breast additional variables malignancy magnetic resonance imaging MRI invasive procedures levels PCr GPC spectra markers hormonal receptor status breast carcinomas addition ER PgR content prediction response hormonal therapy Additional development situ MRI MRS studies 